[Non-invasive assessment of coronary microvascular function in patients with syndrome X using exercise and rest myocardial SPECT with 99mTc-tetrofosmin].
The purpose of this study was to evaluate impaired coronary microvascular function in Syndrome X (Sx) by measuring % uptake increase in myocardial counts. Global and regional myocardial uptake was determined with 99mTc-tetrofosmin and a 4-hour exercise (370 MBq i.v.) and rest (740 MBq i.v.) protocol, in 11 patients with anginal syndrome and normal coronary arteriograms (Sx) and in 10 control subjects (C). The parameter of % uptake increase (delta MTU) was calculated as the ratio of exercise counts to rest myocardial counts with correction of myocardial uptake for dose administered and physical decay between the exercise study and the rest study. Global delta MTU was significantly lower in Sx than C (12.9 +/- 5.4% vs. 22.3 +/- 10.8%, p < 0.05). Regional delta MTU in each of 4 left ventricular regions (anterior, septal, inferior, posterolateral) was significantly lower in Sx than in C (p < 0.05), except for the inferior region. However, there were no significant differences between delta MTU in the 4 left ventricular regions in the same group. None of the patients with Sx exhibited an ischemic pattern in the ST-segment/heart rate loop. delta MTU was useful as a non-invasive means of evaluating impaired coronary microvascular function in Sx.
Tsujimoto
G
G
Department of Internal Medicine, Kobe Rosai Hospital.
D000368:Aged; D003326:Coronary Circulation / Q000502:physiology*; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000502:physiology; D017566:Microvascular Angina / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin